BioAge Labs BIOA
NASDAQ BIOA
$6.81 -0.28 (-3.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

BioAge Labs (BIOA) Net Equity Issued and Repurchased (2024 - 2026)

Updated

BioAge Labs (BIOA) reported Net Equity Issued and Repurchased of $1.47 million for Q2 2026, down 13.7% from the prior quarter.

Analysis

BioAge Labs (BIOA) Net Equity Issued and Repurchased (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, BioAge Labs' Net Equity Issued and Repurchased came in at $20.34 million, down 51.3% year-over-year; for FY2025, it was $17.16 million, down 91.9% from FY2024.

  • By year, Net Equity Issued and Repurchased came in at $211.76 million in FY2024 and $4,000 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 BioAge Labs 324.56 Mn 324.56 Mn -14.23 Mn 1.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.47 Mn
Mar 31, 2026 1.71 Mn
Dec 31, 2025 17.16 Mn
Dec 31, 2024 27.62 Mn
Sep 30, 2024 14.14 Mn
Mar 31, 2024 170.00 Mn
API Access

BioAge Labs Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=BIOA&period=max&api_key=YOUR_API_KEY